| Aug 8 |
PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
|
| Aug 7 |
PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024
|
| Aug 2 |
PDS Biotechnology Corporation (PDSB) Clinical Program Update Conference Call (Transcript)
|
| Aug 1 |
PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer
|
| Jul 31 |
PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time
|
| Jul 29 |
PDS Biotech to Participate at BTIG Virtual Biotechnology Conference
|
| Jun 12 |
PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in Head and Neck Cancer
|
